A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...] …
Articles by : William Newton, Associate Editor/Senior Writer
Maxor, a leading integrated pharmacy services and 340B solutions provider first established nearly 100 years ago in a small Texas [...] …
In the final hour of Oklahoma’s 2025 legislative session, as the clock neared 11 p.m. on May 29, state legislators [...] …
Novartis and Bristol Myers Squibb (BMS) are asking a federal appeals court to expedite their challenge to a recent ruling [...] …
A late amendment to Indiana’s newly enacted budget law grants the state broad authority to restrict how 340B drugs are [...] …
The Oregon Legislature yesterday sent a 340B contract pharmacy access bill to the state’s governor, shortly after Illinois lawmakers failed [...] …
Pharmaceutical giant AbbVie has sued Hawaii over its 340B contract pharmacy access law just three days after the governor signed [...] …
The Department of Health and Human Services (HHS) has submitted proposed 340B rebate guidance for regulatory review—but it is unclear [...] …
The governors of Colorado and Hawaii have signed new laws that bar drugmakers from restricting 340B contract pharmacy access and [...] …
Breaking News
Trump’s Full 2026 Budget Request Would Shift 340B Program from HRSA to CMS, Maintain Current OPA Funding
President Donald Trump’s fiscal year 2026 budget request released yesterday calls for moving control of the 340B program away from [...] …